SCHEMBL299507

SCHEMBL299507

CCC(=O)N1CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7247970 0.97 L3MBTL1 (0.59) —
SCHEMBL14518698 0.97 L3MBTL1 (0.59) —
Ammonia Solution, Strong SCHEMBL27829669 0.97 L3MBTL1 (0.56) —
SCHEMBL18373912 0.97 L3MBTL1 (0.59) —
SCHEMBL11558147 0.97 L3MBTL1 (0.59) —
SCHEMBL18373854 0.97 L3MBTL1 (0.59) —
SCHEMBL765761 0.97 L3MBTL1 (0.59) —
Hydrochloric Acid SCHEMBL5556862 0.97 L3MBTL1 (0.56) —
SCHEMBL21765879 0.97 L3MBTL1 (0.56) —
Hydrochloric Acid SCHEMBL5552770 0.97 L3MBTL1 (0.56) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 705 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024204554-A1 SPIROCYCLIC MORPHINAN DERIVATIVE 日本ケミファ株式会社 2024-10-03 — — WO claimed
EP-3512852-B1 TRAF 6 INHIBITORS HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM GESUNDHEIT & UMWELT GMBH (DE) 2024-06-26 — — EP claimed
CN-114034787-B Method for measuring sensory related amide compounds in main stream smoke of cigarettes 中国烟草总公司郑州烟草研究院 2024-05-03 — — CN claimed
CN-114034790-B Method for determining sensory related amide compounds in tobacco and tobacco products 中国烟草总公司郑州烟草研究院 2024-03-08 — — CN claimed
CN-115716860-A 15 beta- [ 3-propionylamino ] -substituted estra-1, 3,5 (10) -trien-17-ones and 17-oximes 佛恩多制药有限公司 2023-02-28 — — CN claimed
EP-3590933-B1 PYRAZOLE AMINOPYRIMIDINE DERIVATIVES AS LRRK2 MODULATORS GENENTECH INC (US) 2021-01-06 — — EP claimed
EP-2638031-B9 PYRAZOLE AMINOPYRIMIDINE DERIVATIVES AS LRRK2 MODULATORS GENENTECH INC (US) 2020-01-08 — — EP claimed
EP-3124483-B1 PYRAZOLE AMINOPYRIMIDINE DERIVATIVES AS LRRK2 MODULATORS GENENTECH INC (US) 2019-07-10 — — EP claimed
EP-2638031-B1 PYRAZOLE AMINOPYRIMIDINE DERIVATIVES AS LRRK2 MODULATORS GENENTECH INC (US) 2017-10-11 — — EP claimed
CN-106978350-A One plant of aspergillus niger and its application in the preparation of Pu'er tea chlorins compound 北京大学 2017-07-25 — — CN claimed
EP-3124483-A1 PYRAZOLE AMINOPYRIMIDINE DERIVATIVES AS LRRK2 MODULATORS F. Hoffmann-La Roche AG (CH) 2017-02-01 — — EP claimed
WO-2016162215-A1 POLYMER DISPERSIONS CONTAINING N-ACYLPYRROLIDINES BASF SE (DE) 2016-10-13 — — WO claimed
CN-103313978-B Pyrazole aminopyrimidine derivatives as LRRK2 modulators HOFFMANN LA ROCHE 2015-04-15 — — CN claimed
EP-2638031-A1 PYRAZOLE AMINOPYRIMIDINE DERIVATIVES AS LRRK2 MODULATORS F.HOFFMANN-LA ROCHE AG (CH) 2013-09-18 — — EP claimed
WO-2012062783-A1 PYRAZOLE AMINOPYRIMIDINE DERIVATIVES AS LRRK2 MODULATORS F. HOFFMANN-LA ROCHE AG (CH) 2012-05-18 — — WO claimed
CN-1942179-A Alpha-aminoamide derivatives useful in the treatment of restless legs syndrome and addictive disorders NEWRON PHARM SPA (IT) 2007-04-04 — — CN claimed
EP-4644380-A1 PYRIDAZINE NLRP3 INHIBITOR COMPOUND, PHARMACEUTICAL COMPOSITION, AND PREPARATION METHOD THEREFOR AND USE THEREOF Changchun Genescience Pharmaceutical Co., Ltd. (CN) 2025-11-05 — — EP disclosed
WO-2025226510-A1 LPAR1 INHIBITORS ABBVIE INC. (US) 2025-10-30 — — WO disclosed
US-4105763-A 1-Methyl-2-(phenyl-oxymethyl)-5-nitro-imidazoles HOECHST AKTIENGESELLSCHAFT (DE) 1978-08-08 — — US disclosed
US-4078086-A Anthraquinone-bis-amidines and process for preparing them HOECHST AKTIENGESELLSCHAFT (DT) 1978-03-07 — — US disclosed
Send feedback